Biosimilar Antibodies

Gentaur supplies research-grade biosimilar antibodies designed for non-clinical studies that mirror the structure and function of FDA-approved biologics. These antibodies include equivalents to Adalimumab, Nivolumab, Trastuzumab, Rituximab, Palivizumab, and more. Each product is validated by ELISA, FCM, functional assays, and tested for high-affinity target binding (e.g., TNFα, PD-1, HER2, RSV). Ideal for mechanistic studies, antibody engineering, and immune modulation assays.

Key targets: TNFα, PD-1, IL4RA, ERBB2, RSV, STEAP1, APP, IL31RA, IL12B